Three technologies that will shape biotech in 2026 | MIT Technology Review

MIT Technology Review highlights three transformative biotech technologies for 2026: personalized gene editing, genetic resurrections, and embryo scoring. Personalized gene editing, exemplified by the successful treatment of a baby with a rare genetic disorder, offers hope for accessible treatments for genetic diseases. Genetic resurrections, such as creating 'woolly mice' and dire wolves, demonstrate the potential of ancient DNA analysis and cloning in conservation and de-extinction efforts. Embryo scoring, while evolving to include screening for genetic diseases, has sparked controversy with the potential to select embryos for traits like height and intelligence.